60 related articles for article (PubMed ID: 16715656)
1. Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma.
Wang HC; Hsiao HH; Du JS; Cho SF; Yeh TJ; Gau YC; Liu YC; Moi SH
Biomed Res Int; 2021; 2021():3291762. PubMed ID: 34631879
[TBL] [Abstract][Full Text] [Related]
2. Surgical resection versus biopsy in the treatment of primary central nervous system lymphoma: a systematic review and meta-analysis.
Chojak R; Koźba-Gosztyła M; Polańska K; Rojek M; Chojko A; Bogacz R; Skorupa N; Więcław J; Czapiga B
J Neurooncol; 2022 Dec; 160(3):753-761. PubMed ID: 36449256
[TBL] [Abstract][Full Text] [Related]
3. All-cause and tumor-specific mortality trends in elderly primary central nervous system lymphoma (PCNSL) patients: a surveillance, epidemiology, and end results (SEER) analysis.
Furst T; Hoffman H; Chin LS
J Neurosurg Sci; 2024 Feb; 68(1):44-50. PubMed ID: 31601065
[TBL] [Abstract][Full Text] [Related]
4. Have we reached the end of the road for radiation therapy in primary central nervous system lymphoma?
Kaliyath SB; Sharma DN
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1018-S1019. PubMed ID: 38261455
[No Abstract] [Full Text] [Related]
5. Radiation therapy for primary central nervous system lymphoma.
Shibamoto Y
Oncol Rev; 2013 Apr; 7(1):e4. PubMed ID: 25992225
[TBL] [Abstract][Full Text] [Related]
6. Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004.
Shibamoto Y; Sumi M; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H; Abe E; Koizumi M; Miyawaki D; Kubota S; Ogo E; Nomiya T; Takemoto M; Harada H; Takahashi I; Ohmori Y; Ishibashi N; Tokumaru S; Suzuki K
Int J Clin Oncol; 2014 Oct; 19(5):963-71. PubMed ID: 24297187
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004.
Shibamoto Y; Ogino H; Suzuki G; Takemoto M; Araki N; Isobe K; Tsuchida E; Nakamura K; Kenjo M; Suzuki K; Hosono M; Tokumaru S; Ishihara S; Kato E; Ii N; Hayabuchi N
Neuro Oncol; 2008 Aug; 10(4):560-8. PubMed ID: 18559969
[TBL] [Abstract][Full Text] [Related]
8. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
10. Results of primary central nervous system lymphoma treated by radiation and chemotherapy: retrospective analysis of twelve institutions in the Tokai District of Japan, 1995-1999.
Kawamura T; Ishiguchi T; Shibamoto Y; Ogino H; Ishihara S; Yamada T; Katada K; Suzuki K; Suzuki H; Mimura M
Radiat Med; 2006 Jan; 24(1):9-16. PubMed ID: 16715656
[TBL] [Abstract][Full Text] [Related]
11. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma in Japan: a nationwide survey.
Hayabuchi N; Shibamoto Y; Onizuka Y
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):265-72. PubMed ID: 10760418
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
Herrlinger U; Schabet M; Brugger W; Kortmann RD; Kanz L; Bamberg M; Dichgans J; Weller M
Cancer; 2001 Jan; 91(1):130-5. PubMed ID: 11148569
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with primary central nervous system lymphoma treated outside clinical trials.
Hart A; Baars JW; Kersten MJ; Brandsma D; van Tinteren H; de Jong D; Spiering M; Dewit L; Boogerd W
Neth J Med; 2014 May; 72(4):218-23. PubMed ID: 24829178
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
